A step closer to a Chikungunya vaccine

Chikungunya is a mosquito-borne disease which spreads to humans and can cause fever and severe joint pain, sometimes felt long term. It’s most common in Africa, Asia, and the Americas. But just like better known diseases Dengue and Zika, outbreaks look set to become more widespread as the world warms. We hear from Josie Shillito who caught Chikungunya while working on the island of Réunion. And Reader in Virus Evolution at Imperial College London, Dr Nuno R. Faria gives his reaction to news of the first phase three vaccination trial for the disease.In the first of a new series where we try to answer your health questions, we hear from Steve from New Zealand who wants to know about the connection between migraines and vertigo. Dr Michael Strupp, Professor of Neurology and Clinical Neurophysiology at the University of Munich sheds some light.BBC health reporter Philippa Roxby joins Claudia Hammond to discuss the latest health research. This week we hear about a shortage of blood available for transfusions across Sub-Saharan Africa. A study from the US estimating how many lives of people with covid would have been saved if the vaccines had been shared evenly around the world; How a drug more commonly used to treat diabetes might lower the risk of developing long covid. And a study from Taiwan where subterranean robots have been used to destroy mosquito breeding sites in sewers.Image Credit: ReutersPresenter: Claudia Hammond Producers: Clare Salisbury & Jonathan Blackwell